1. Home
  2. ERAS
  3. ERAS News

Latest Erasca Inc. (ERAS) News on June 25, 2025

Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium

GlobeNewswire

9 months ago

Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium

Business Wire

a year ago

Form 8.3 - Darktrace plc

Share on Social Networks: